Nitric oxide does not significantly contribute to changes in pulse pressure amplification during light aerobic exercise

Hypertension

Volumn 51, Issue 4, 2008, Pages 856-861

  Sharman, James E ^a,b   McEniery, Carmel M ^c   Campbell, Ross ^d   Pusalkar, Pawan ^d   Wilkinson, Ian B ^c   Coombes, Jeff S ^b   Cockcroft, John R ^d  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b Exercise and Oxidative Stress Research Group   (Australia)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Aorta; Exercise; Hemodynamics; NO; Radial artery

Indexed keywords

ARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; NORADRENALIN; SODIUM CHLORIDE; ENZYME INHIBITOR; N(G) METHYLARGININE; VASOCONSTRICTOR AGENT;

ADULT; AEROBIC EXERCISE; ARTERIAL STIFFNESS; ARTICLE; AUGMENTATION INDEX; BLOOD PRESSURE; HEART OUTPUT; HEART RATE; HEART STROKE VOLUME; HUMAN; IMPEDANCE; INFUSION; MALE; MEAN ARTERIAL PRESSURE; PRIORITY JOURNAL; PULSE PRESSURE; PULSE WAVE; STATISTICAL SIGNIFICANCE; VASCULAR RESISTANCE; AORTA; BRACHIAL ARTERY; CLINICAL TRIAL; COMPARATIVE STUDY; DRUG EFFECT; EXERCISE; METABOLISM; PHYSIOLOGY; PULSATILE FLOW; RADIAL ARTERY;

ADULT; AORTA; BLOOD PRESSURE; BRACHIAL ARTERY; ENZYME INHIBITORS; EXERCISE; HUMANS; MALE; NITRIC OXIDE; NOREPINEPHRINE; OMEGA-N-METHYLARGININE; PULSATILE FLOW; RADIAL ARTERY; SODIUM CHLORIDE; VASOCONSTRICTOR AGENTS;

EID: 42049085931     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.107.102558     Document Type: Article

References (48)

1. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903-1913.
2. Mundal R, Kjeldsen SE, Sandvik L, Erikssen G, Thaulow E, Erikssen J. Exercise blood pressure predicts cardiovascular mortality in middle- aged men. Hypertension. 1994;24:56-62.
3. Mundal R, Kjeldsen SE, Sandvik L, Erikssen G, Thaulow E, Erikssen J. Exercise blood pressure predicts mortality from myocardial infarction. Hypertension. 1996;27:324-329.
4. Marchais SJ, Guerin AP, Pannier BM, Levy BI, Safar ME, London GM. Wave reflections and cardiac hypertrophy in chronic uremia. Influence of body size. Hypertension. 1993;22:876-883.
5. Sharman JE, Fang ZY, Haluska B, Stowasser M, Prins JB, Marwick TH. Left ventricular mass in patients with type 2 diabetes mellitus is independently associated with central but not peripheral pulse pressure. Diabetes Care. 2005;28:937-939.
6. Boutouyrie P, Bussy C, Lacolley P, Girerd X, Laloux B, Laurent S. Association between local pulse pressure, mean blood pressure, and large-artery remodelling. Circulation. 1999;100:1387-1393.
7. London GM, Blacher J, Pannier B, Guerin AP, Marchais SJ, Safar ME. Arterial wave reflections and survival in end-stage renal failure. Hypertension. 2001;38:434-438.
8. Safar ME, Blacher J, Pannier B, Guerin AP, Marchais SJ, Guyonvarc'h PM, London GM. Central pulse pressure and mortality in end-stage renal disease. Hypertension. 2002;39:735-738.
9. Weber T, Auer J, O'Rourke MF, Kvas E, Lassnig E, Lamm G, Stark N, Rammer M, Eber B. Increased arterial wave reflections predict severe cardiovascular events in patients undergoing percutaneous coronary interventions. Eur Heart J. 2005;26:2657-2663.
10. Roman MJ, Devereux RB, Kizer JR, Lee ET, Galloway JM, Ali T, Umans JG, Howard BV. Central pressure more strongly relates to vascular disease and outcome than does brachial pressure: the Strong Heart Study. Hypertension. 2007;50:197-203.
11. Wilkinson IB, Franklin SS, Hall IR, Tyrrell S, Cockcroft JR. Pressure amplification explains why pulse pressure is unrelated to risk in young subjects. Hypertension. 2001;38:1461-1466.
12. Wilkinson IB, Prasad K, Hall IR, Thomas A, MacCallum H, Webb DJ, Frenneaux MP, Cockcroft JR. Increased central pulse pressure and augmentation index in subjects with hypercholesterolemia. J Am Coll Cardiol. 2002;39:1005-1011.
13. Sharman JE, McEniery CM, Campbell R, Coombes JS, Wilkinson IB, Cockcroft JR. The effect of exercise on large artery hemodynamics in healthy young men. Eur J Clin Invest. 2005;35:738-744.
14. Sharman JE, McEniery CM, Dhakam ZR, Coombes JS, Wilkinson IB, Cockcroft JR. Pulse pressure amplification during exercise is significantly reduced with age and hypercholesterolemia. J Hypertens. 2007;25:1249-1254.
15. Chowienczyk PJ, Watts GF, Cockcroft JR, Ritter JM. Impaired endothelium-dependent vasodilation of forearm resistance vessels in hypercholesterolaemia. Lancet. 1992;340:1430-1432.
16. Tamai O, Matsuoka H, Itabe H, Wada Y, Kohno K, Imaizumi T. Single LDL apheresis improves endothelium-dependent vasodilatation in hypercholesterolemic humans. Circulation. 1997;95:76-82.
17. Schmitt M, Avolio A, Qasem A, McEniery CM, Butlin M, Wilkinson IB, Cockcroft JR. Basal NO locally modulates human iliac artery function in vivo. Hypertension. 2005;46:227-231.
18. Vallance P, Collier J, Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet. 1989;2:997-1000.
19. Haynes WG, Noon JP, Walker BR, Webb DJ. Inhibition of nitric oxide synthesis increases blood pressure in healthy humans. J Hypertens. 1993;11:1375-1380.
20. Wilkinson IB, MacCallum H, Cockcroft JR, Webb DJ. Inhibition of basal nitric oxide synthesis increases aortic augmentation index and pulse wave velocity in vivo. Br J Clin Pharmacol. 2002;53:189-192.
21. Kingwell BA, Berry KL, Cameron JD, Jennings GL, Dart AM. Arterial compliance increases after moderate-intensity cycling. Am J Physiol Heart Circ Physiol. 1997;273:H2186-H2191.
22. Naka KK, Tweddel AC, Parthimos D, Henderson A, Goodfellow J, Frenneaux MP. Arterial distensibility: acute changes following dynamic exercise in normal subjects. Am J Physiol Heart Circ Physiol. 2003;284:H970-H978.
23. Green D, Cheetham C, Mavaddat L, Watts K, Best M, Taylor R, O'Driscoll G. Effect of lower limb exercise on forearm vascular function: contribution of nitric oxide. Am J Physiol Heart Circ Physiol. 2002;283:H899-H907.
24. Gilligan DM, Panza JA, Kilcoyne CM, Waclawiw MA, Casino PR, Quyyumi AA. Contribution of endothelium-derived nitric oxide to exercise-induced vasodilation. Circulation. 1994;90:2853-2858.
25. Sharman JE, Scott JA, Coombes JS, Prins JB, Leano R, Marwick TH. Patients with type 2 diabetes mellitus have an exaggerated brachial and central blood pressure response to exercise: Relation to left ventricular hypertrophy [abstract]. Hypertension. 2007;49:72.
26. Wilkinson IB, Hall IR, MacCallum H, Mackenzie IS, McEniery CM, van der Arend BJ, Shu YE, MacKay LS, Webb DJ, Cockcroft JR. Pulse-wave analysis: clinical evaluation of a noninvasive, widely applicable method for assessing endothelial function. Arterioscler Thromb Vasc Biol. 2002;22:147-152.
27. Taylor R, Chidley K, Goodwin J, Broeders M, Kirby B. Accutracker II (version 30/23) ambulatory blood pressure monitor: clinical validation using the British Hypertension Society and Association for the Advancement of Medical Instrumentation standards. J Hypertens. 1993;11:1275-1282.
28. White WB, Lund-Johansen P, Omvik P. Assessment of four ambulatory blood pressure monitors and measurements by clinicians versus intraarterial blood pressure at rest and during exercise. Am J Cardiol. 1990;65:60-66.
29. Sharman JE, Lim R, Qasem AM, Coombes JS, Burgess MI, Franco J, Garrahy P, Wilkinson IB, Marwick TH. Validation of a generalized transfer function to noninvasively derive central blood pressure during exercise. Hypertension. 2006;47:1203-1208.
30. Holland DJ, Sacre JW, McFarlane SI, Coombes JS, Marwick TH, Sharman JE. Pulse wave analysis is a reproducible technique for noninvasive measurement of central blood pressure and wave reflection during exercise [abstract]. Heart Lung Circ. 2007;16:S164-S165.
31. Safar ME, London GM. Therapeutic studies and arterial stiffness in hypertension: recommendations of the European Society of Hypertension. The clinical committee of arterial structure and function. Working group on vascular structure and function of the European Society of Hypertension. J Hypertens. 2000;18:1527-1535.
32. McEniery CM, Yasmin, Hall IR, Qasem A, Wilkinson IB, Cockcroft JR. Normal vascular aging: differential effects on wave reflection and aortic pulse wave velocity: the Anglo-Cardiff Collaborative Trial (ACCT). J Am Coll Cardiol. 2005;46:1753-1760.
33. Fortin J, Haitchi G, Bojic A, Habenbacher W, Grullenberger R, Heller A, Pacher R, Wach P, Skrabal F. Validation and Verification of the Task Force Monitor. Institute for Biomedical Engineering, Department of Biophysics; 2001:1-7.
34. Boushel R, Langberg H, Gemmer C, Olesen J, Crameri R, Scheede C, Sander M, Kjaer M. Combined inhibition of nitric oxide and prostaglandins reduces human skeletal muscle blood flow during exercise. J Physiol. 2002;543:691-698.
35. Langberg H, Bjorn C, Boushel R, Hellsten Y, Kjaer M. Exercise-induced increase in interstitial bradykinin and adenosine concentrations in skeletal muscle and peritendinous tissue in humans. J Physiol. 2002;542:977-983.
36. Martin EA, Nicholson WT, Eisenach JH, Charkoudian N, Joyner MJ. Bimodal distribution of vasodilator responsiveness to adenosine due to difference in nitric oxide contribution: implications for exercise hyperemia. J Appl Physiol. 2006;101:492-499.
37. Duffy SJ, New G, Tran BT, Harper RW, Meredith IT. Relative contribution of vasodilator prostanoids and NO to metabolic vasodilation in the human forearm. Am J Physiol. 1999;276:H663-H670.
38. Dyke CK, Proctor DN, Dietz NM, Joyner MJ. Role of nitric oxide in exercise hyperaemia during prolonged rhythmic handgripping in humans. J Physiol. 1995;488:259-265.
39. Frandsenn U, Bangsbo J, Sander M, Hoffner L, Betak A, Saltin B, Hellsten Y. Exercise-induced hyperaemia and leg oxygen uptake are not altered during effective inhibition of nitric oxide synthase with N(G)-nitro-L-arginine methyl ester in humans. J Physiol. 2001;531:257-264.
40. Endo T, Imaizumi T, Tagawa T, Shiramoto M, Ando S, Takeshita A. Role of nitric oxide in exercise-induced vasodilation of the forearm. Circulation. 1994;90:2886-2890.
41. Gordon MB, Jain R, Beckman JA, Creager MA. The contribution of nitric oxide to exercise hyperemia in the human forearm. Vasc Med. 2002;7:163-168.
42. Wilson JR, Kapoor S. Contribution of endothelium-derived relaxing factor to exercise-induced vasodilation in humans. J Appl Physiol. 1993;75:2740 -2744.
43. Shoemaker JK, Halliwill JR, Hughson RL, Joyner MJ. Contributions of acetylcholine and nitric oxide to forearm blood flow at exercise onset and recovery. Am J Physiol. 1997;273:H2388-H2395.
44. Joyner MJ, Wilkins BW. Exercise hyperaemia: is anything obligatory but the hyperaemia? J Physiol. 2007;583:855-860.
45. Munir SM, Jiang B, Guilcher A, Brett S, Redwood S, Chowienczyk PJ. Effects of inhibition of nitric oxide synthase on the peripheral arterial waveform response to exercise [abstract]. Br J Clin Pharmacol. 2007;63:778.
46. Singh JP, Larson MG, Manolio TA, O'Donnell CJ, Lauer M, Evans JC, Levy D. Blood pressure response during treadmill testing as a risk factor for new-onset hypertension: the Framingham Heart Study. Circulation. 1999;99:1831-1836.
47. Kurl S, Laukkanen JA, Rauramaa R, Lakka TA, Sivenius J, Salonen JT. Systolic blood pressure response to exercise stress test and risk of stroke. Stroke. 2001;32:2036-2041.
48. Filipovsky J, Ducimetiere P, Safar ME. Prognostic significance of exercise blood pressure and heart rate in middle-aged men. Hypertension. 1992;20:333-339.